Physician

Abubakr Akhtar Bajwa, M.D.

According to 2025 Medicare claims, Abubakr Bajwa, M.D. (NPI: 1467442392) practices pulmonary disease in the Jacksonville, FL market, with the plurality of this provider's patient population coming from Duval, FL. This provider's primary affiliated billing organization is MAYO CLINIC JACKSONVILLE (NPI: 1790772317; TIN: 593337028) and primary practice location at 32224-1865. Bajwa is affiliated with the St Vincents Accountable Care Organization LLC (ACO ID: A2205) and UF HEALTH ACO JACKSONVILLE, LLC (ACO ID: A5465), participating under the MSSP model.

Bajwa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,746 traditional Medicare patients, billed 4,619 HCPCS/CPT codes, and received $195,302 in Medicare payments. The top billing code was 94726 (Test to determine lung volumes using sensors). Part D data shows 578 prescription claims across 158 beneficiaries totaling $2,349,898 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 997 claims. Open Payments data shows 38 records totaling $48,192. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $2,322,301 to $2,349,898. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $57,488 to $73,859.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$98K$195K2015 Medicare payment: $127,612 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $117,231 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $122,635 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $104,777 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $102,996 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $116,903 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $120,301 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $130,682 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $110,077 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $195,302 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154331,191$127,612
20164971,261$117,231
20176071,225$122,635
20185821,228$104,777
20195591,131$102,996
20205941,499$116,903
20216041,368$120,301
20226621,432$130,682
20238161,641$110,077
20241,7464,619$195,302

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$6.8M$14M2015 Drug cost: $2,322,301 (USD; Tot_Drug_Cst)2016 Drug cost: $3,327,420 (USD; Tot_Drug_Cst)2017 Drug cost: $2,844,918 (USD; Tot_Drug_Cst)2018 Drug cost: $2,575,053 (USD; Tot_Drug_Cst)2019 Drug cost: $5,725,102 (USD; Tot_Drug_Cst)2020 Drug cost: $8,326,342 (USD; Tot_Drug_Cst)2021 Drug cost: $10,669,389 (USD; Tot_Drug_Cst)2022 Drug cost: $11,676,488 (USD; Tot_Drug_Cst)2023 Drug cost: $13,620,530 (USD; Tot_Drug_Cst)2024 Drug cost: $2,349,898 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201595772$2,322,301
2016104874$3,327,420
20171941,083$2,844,918
20182351,194$2,575,053
20192921,786$5,725,102
20203752,832$8,326,342
20214382,886$10,669,389
20225183,602$11,676,488
20234533,079$13,620,530
2024158578$2,349,898

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$533K$1.1M2015 Medicare payment: $626,896 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $571,652 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $152,924 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $406,385 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $490,431 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,065,988 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $937,919 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $784,730 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $288,116 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $73,291 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20155221,428$626,896
20163971,140$571,652
20174611,196$152,924
20184911,360$406,385
20196621,905$490,431
20206622,234$1,065,988
20217202,285$937,919
20225881,939$784,730
20235641,800$288,116
2024327997$73,291

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
94726Test to determine lung volumes using sensors652661$41
94729Test to examine how well the lungs exchange gases853886$40
94060Test to measure expiratory airflow and volume changes before and after medication administration361368$28
94010Test to measure expiratory airflow and volume671787$19
94618Test for exercise-induced lung stress221235$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OfevNintedanib Esylate601,770$767,466
Tyvaso DpiTreprostinil22616$523,952
Orenitram ErTreprostinil Diolamine14420$434,565
UptraviSelexipag15427$273,187
OpsumitMacitentan12360$150,849

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0483High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, eachYN/R22$19,902
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY28158$12,330
E0466Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)YN/R12$12,065
A7031Face mask interface, replacement for full face mask, eachN1950$4,200
A7034Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strapN3379$3,786

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.30$6,160Actelion Pharmaceuticals US, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.8$42,032AstraZeneca Pharmaceuticals LP
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abubakr Akhtar Bajwa, M.D.?

Tedicare shows public-source Medicare data for Abubakr Akhtar Bajwa, M.D. (NPI 1467442392), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abubakr Akhtar Bajwa, M.D. have ACO affiliation data?

Abubakr Akhtar Bajwa, M.D. is shown with ACO affiliation data for St Vincents Accountable Care Organization LLC (MSSP, ACO ID A2205) and UF HEALTH ACO JACKSONVILLE, LLC (MSSP, ACO ID A5465).

What billing organization is linked to Abubakr Akhtar Bajwa, M.D.?

Abubakr Akhtar Bajwa, M.D. is linked to MAYO CLINIC JACKSONVILLE (billing NPI 1790772317) in the available physician profile data.

Does Abubakr Akhtar Bajwa, M.D. have Open Payments data?

Abubakr Akhtar Bajwa, M.D. has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.